InsidersTradesSigma
innoscripta SE Stock: price and insider trades · Germany · BaFin
Track the innoscripta SE stock price and the full management transaction log of the company, a listed equity based in Germany. Shares are listed on DE DE, under the oversight of BaFin. Operating in the Technology sector, innoscripta SE has logged 25 insider filings. Market capitalisation: €778m. The latest transaction was disclosed on 10 March 2026 (Buy). Among the most active insiders: Hohenester Beteiligungs-UG (haftungsbeschränkt). The full history is accessible without an account.
25
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
17Σ signal
Fundamental score
Ranked 1,938 of 26,220 companies
76.3
score / 100
Value60
Quality93
FCF yld5.2%
Earn yld5.5%
EV/EBITDA12.4x
ROE85%
Gross mgn74%
Net mgn41%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 March 2026
Declarations25 total
78,900 shares@ €70.000.60% mcap44.9% of flowShareBAFIN:40035913-367b49115a6d
10,000 shares@ €91.377.4% of flowShareXETRABAFIN:40035913-7d694b56aca0
4,899.744 shares@ €66.3339.0% of flowShareBAFIN:40035913-71f2130eca16
4,899.744 shares@ €66.332.6% of flowShareBAFIN:40035913-0d58d49f737c
91.997 shares@ €84.590.1% of flowShareXETRABAFIN:40035913-98be475748f1
1,582.046 shares@ €84.171.1% of flowShareXETRABAFIN:40035913-ec4f9d335d9b
58 shares@ €85.000.0% of flowShareXETRABAFIN:40035913-c4cbfc405bad
2,774.062 shares@ €81.661.8% of flowShareXETRABAFIN:40035913-58c5a5de7aa7
3,379.01 shares@ €81.682.2% of flowShareXETRABAFIN:40035913-1121e57b1b1c
1,613.02 shares@ €83.711.1% of flowShareXETRABAFIN:40035913-7b5b3cbf1795
883.996 shares@ €84.870.6% of flowShareXETRABAFIN:40035913-7aefbbeeff36
1,399.06 shares@ €84.881.0% of flowShareXETRABAFIN:40035913-dec35bd6355c
13,255.594 shares@ €94.0710.1% of flowShareXETRABAFIN:40035913-60765ba5d913
10,713.595 shares@ €99.338.7% of flowShareXETRABAFIN:40035913-d3f61ad796b0
7,499.842 shares@ €91.845.6% of flowShareXETRABAFIN:40035913-760e4753a2af
1,050.023 shares@ €92.0911.6% of flowShareXETRABAFIN:40035913-ddb3225ec285
799.991 shares@ €108.570.7% of flowShareXETRABAFIN:40035913-890a22b32dab
199.998 shares@ €108.572.6% of flowShareXETRABAFIN:40035913-2dcd91211bb2
6,400.219 shares@ €104.985.5% of flowShareXETRABAFIN:40035913-1419b88a9a79
6,400.248 shares@ €103.075.4% of flowShareXETRABAFIN:40035913-02129e941793
1,600.055 shares@ €104.9820.2% of flowShareXETRABAFIN:40035913-7329867542c1
1,600.062 shares@ €103.0719.8% of flowShareXETRABAFIN:40035913-0d309549844d
1,666.909 shares@ €84.311.1% of flowShareXetraBAFIN:40035913-9e60c9222f7d
332.982 shares@ €84.313.4% of flowShareXetraBAFIN:40035913-face7f7d76f2
332.982 shares@ €84.313.4% of flowShareXetraBAFIN:40035913
25 of 25 declarations
About innoscripta SE
Geographically, innoscripta remains strongly anchored in its home market of Germany while expanding internationally. The group has established offices in Austria, Cologne and Istanbul, and in 2026 it announced new offices in France near Toulouse and in the United States, with additional UK development also highlighted. This expansion is designed to capture growing demand for R&D incentives across OECD markets, where tax-based support mechanisms and documentation requirements are becoming increasingly important. Recent corporate milestones include its IPO and first trading day on May 23, 2025 in the Scale segment, the legal conversion into innoscripta SE, and management’s stated push for further international growth. For investors, the equity story combines software scalability, regulatory tailwinds and an expanding geographic footprint, while remaining exposed to changes in subsidy frameworks and market adoption of R&D compliance tools.
